Apaf-1 is a transcriptional target for E2F and p53
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“abnormal proliferation that is induced by loss of RB is often accompanied by increased cell death, through p53-dependent and independent mechanisms49,57,87–91.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [90]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“Consistent with this role, the pRB pathway is deregulated in most human cancers (reviewed in ref”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 1×
“The best-characterized targets for the pRB family members are the E2F transcription factor”
BackgroundA Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523 · cited 1×
“Increased levels of Apaf-1 as a result of increased E2F activity could provide an explanation for the greater sensitivity of tumour cells to a variety of apoptosis-inducing agents, including chemotherapeutic drug”
BackgroundApaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138 · cited 1×
“Apaf-1 is an essential stimulator of caspase activity and is required for stress- and oncogene-induced apoptosi”
BackgroundThe coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35004029 · Cited by 1,071
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966 · cited 1×
“This suggestion was further substantiated by results—published while this manuscript was undergoing review—showing that Apaf-1 expression is lost in a number of malignant melanomas owing to a combination of allelic loss and transcriptional silencin”
Resultp73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
Cited by
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A., & D'Orazi, G. (2016) · Aging · doi:10.18632/aging.100934 · Cited by 1,658
“, Apaf-1, caspase-6, and Bid) does not efficiently induce apoptosis per se but rather sensitizes cancer cells to the effects of chemotherapeutic agents, improving the apoptotic outcome [124-127].”
BackgroundOrganelle-specific initiation of cell death pathways
Ferri, K. F., & Kroemer, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e255 · Cited by 1,456
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
“This induction by p53 is boosted by E2F1, which induces APAF-1 expression, and activates p53 in an ARF-dependent manner (Moroni et al., 2001).”
BackgroundDecision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
“sites for each of these two transcription factors, as perhaps best illustrated for the Apaf1 gene.(42) This is probably an example of a broader generic mechanism, where the”
BackgroundCellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
The retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738
The E2F transcriptional network: old acquaintances with new faces
Dimova, D. K., & Dyson, N. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208612 · Cited by 715
Cellular Mechanisms Controlling Caspase Activation and Function
Parrish, A. B., Freel, C. D., & Kornbluth, S. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008672 · Cited by 625
“It is interesting to note that Apaf-1, the adapter protein for caspase-9, can also be transcriptionally regulated by E2F1 and p53 (Fortin et al. 2001; Moroni et al. 2001; Furukawa et al. 2002; Johnson et al. 2007).”
BackgroundFernald, K., & Kurokawa, M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.006 · Cited by 579
E2F target genes: unraveling the biology
Bracken, A. P., Ciro, M., Cocito, A., & Helin, K. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.06.006 · Cited by 576
Self-citationThe E2F family: specific functions and overlapping interests
Attwooll, C., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600481 · Cited by 573
“Indeed studies that evaluated the effect of E2F3 overexpression for a prolonged period of time have shown that E2F3 also triggers apoptosis (Moroni et al, 2001; Lazzerini Denchi and Helin, unpublished results).”
BackgroundSelf-citationThe Coherent Feedforward Loop Serves as a Sign-sensitive Delay Element in Transcription Networks
Mangan, S., Zaslaver, A., & Alon, U. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.049 · Cited by 553
“An example in human cells is E2F, which regulates p73 (and indirectly also p53), and both regulate apoptosis genes such as apaf-1.(32) An additional example involves interferon-g induction in T-cells.”
Backgroundp53 and E2f: partners in life and death
Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498
Fei, P., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206677 · Cited by 498
Ellisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474
“, 1995), while a number of candidate target genes have been implicated in p53dependent apoptosis, including Bax, TRAIL-DR5, PERP, Noxa, and APAF-1 (Miyashita and Reed, 1995; Attardi Leif W. Ellisen,1 Kate D. Ramsayer,1 Cory M. Johannessen,1 Annie Yang,2 Hideyuki Beppu,3 Karolina Minda,1 Jonathan D. Oliner,4,6 Frank Mc…”
BackgroundVermeulen, K., Berneman, Z. N., & Van Bockstaele, D. R. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00267.x · Cited by 461
“E2F has been shown to induce the expression of the © 2003 Blackwell Publishing Ltd, Cell Proliferation, 36, 165–175. pro-apoptotic factor Apaf-1 and evidence suggests a role for E2F in apoptosis following DNA damage (Blattner et al. 1999; Moroni et al. 2001).”
BackgroundInfluentialDissecting p53-dependent apoptosis
Chipuk, J. E., & Green, D. R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401908 · Cited by 453
Direct coupling of the cell cycle and cell death machinery by E2F
Nahle, Z., Polakoff, J., Davuluri, R. V., McCurrach, M. E., Jacobson, M. D., Narita, M., Zhang, M. Q., Lazebnik, Y., Bar-Sagi, D., & Lowe, S. W. (2002) · Nature Cell Biology · doi:10.1038/ncb868 · Cited by 421
BID regulation by p53 contributes to chemosensitivity
Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E., Korsmeyer, S. J., & El-Deiry, W. S. (2002) · Nature Cell Biology · doi:10.1038/ncb866 · Cited by 420
The transcriptional targets of p53 in apoptosis control
Yu, J., & Zhang, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.189 · Cited by 420
Chk2 activates E2F-1 in response to DNA damage
Stevens, C., Smith, L., & La Thangue, N. B. (2003) · Nature Cell Biology · doi:10.1038/ncb974 · Cited by 385
p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis
Hussain, S. P., Amstad, P., He, P., Robles, A., Lupold, S., Kaneko, I., Ichimiya, M., Sengupta, S., Mechanic, L., Okamura, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2287-2 · Cited by 384
“Cytochrome c has been shown to be essential for the Apaf-1 binding to procaspase-9 promoting its dimerization and activation by autocatalysis (55, 56).”
BackgroundThe evolution of diverse biological responses to DNA damage: insights from yeast and p53
Wahl, G. M., & Carr, A. M. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-e277 · Cited by 376
BNIP3 Is an RB/E2F Target Gene Required for Hypoxia-Induced Autophagy
Tracy, K., Dibling, B. C., Spike, B. T., Knabb, J. R., Schumacker, P., & Macleod, K. F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02246-06 · Cited by 369
“The role of pRb in protecting against apoptosis has been attributed to its role in repressing expression of critical cell death regulatory genes, such as those encoding Apaf-1, caspases, and p73 (19, 35, 37).”
BackgroundFusaro, G., Dasgupta, P., Rastogi, S., Joshi, B., & Chellappan, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305171200 · Cited by 348
The role of p53 in chemosensitivity and radiosensitivity
El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206949 · Cited by 337
Signaling Networks That Link Cell Proliferation and Cell Fate
Sears, R. C., & Nevins, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100063200 · Cited by 336
Multiple roles of the tumor suppressor p53
Bargonetti, J., & Manfredi, J. J. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00015 · Cited by 332
E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1
Hsu, J. Y., Reimann, J. D. R., Sørensen, C. S., Lukas, J., & Jackson, P. K. (2002) · Nature Cell Biology · doi:10.1038/ncb785 · Cited by 331
Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis
Hershko, T., & Ginsberg, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312866200 · Cited by 322
GATHER: a systems approach to interpreting genomic signatures
Chang, J. T., & Nevins, J. R. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl483 · Cited by 321
“…assembled a gene expression signature of 231 genes representing E2F activation from standard biochemical experiments (DeGregori et al., 1995; Ohtani et al., 1996; Leone et al., 1998; Moroni et al., 2001) and gene expression microarrays (Ishida et al., 2001; Muller et al., 2001; Black et al., 2003).”
BackgroundApaf-1: Regulation and function in cell death
Shakeri, R., Kheirollahi, A., & Davoodi, J. (2017) · Biochimie · doi:10.1016/j.biochi.2017.02.001 · Cited by 313
Apoptosomes: engines for caspase activation
Adams, J. M., & Cory, S. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00381-2 · Cited by 309
Life and death decisions by the E2F transcription factors
Iaquinta, P. J., & Lees, J. A. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.006 · Cited by 306
“However, subsequent studies performed in a similar manner found that activation of E2F2 or E2F3a could also lead to cell death, although possibly not to the same degree as E2F1 expression [8,9].”
BackgroundRole of the Crosstalk between Autophagy and Apoptosis in Cancer
Su, M., Mei, Y., & Sinha, S. (2013) · Journal of Oncology · doi:10.1155/2013/102735 · Cited by 306
“p53 also activates the expression of APAF-1, a key component of the apoptosome [121].”
Cell cycle regulation of neuronal apoptosis in development and disease
Becker, E. B. E., & Bonni, A. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.12.005 · Cited by 302
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription
Chipuk, J. E., Maurer, U., Green, D. R., & Schuler, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00272-1 · Cited by 299
Liou, A. K. F., Clark, R. S., Henshall, D. C., Yin, X.-M., & Chen, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00005-4 · Cited by 297
The genetics of the E2F family of transcription factors: shared functions and unique roles
DeGregori, J. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00051-3 · Cited by 295
Coordinated regulation of life and death by RB
Chau, B. N., & Wang, J. Y. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc993 · Cited by 292
Love, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00022-8 · Cited by 292
Tanaka, H., Matsumura, I., Ezoe, S., Satoh, Y., Sakamaki, T., Albanese, C., Machii, T., Pestell, R. G., & Kanakura, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00522-1 · Cited by 291
Pancreatic Cancer: Basic and Clinical Aspects
Schneider, G., Siveke, J. T., Eckel, F., & Schmid, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.001 · Cited by 289
The p53 and Mdm2 families in cancer
Michael, D. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00264-7 · Cited by 284
Chaabane, W., User, S. D., El-Gazzah, M., Jaksik, R., Sajjadi, E., Rzeszowska-Wolny, J., & Łos, M. J. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0205-y · Cited by 282
“Other proapoptotic genes such as Bid, Apaf1 and PIDD (p53-induced protein with a death domain) are also defined as transcriptional targets of p53 (Moroni et al. 2001; Sax et al. 2002).”
BackgroundE2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes
Di Stefano, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg613 · Cited by 274
Self-citationYakovlev, A. G., Ota, K., Wang, G., Movsesyan, V., Bao, W.-L., Yoshihara, K., & Faden, A. I. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07439.2001 · Cited by 267
“In addition, Moroni et al. (2001) recently reported that the expression of Apaf-1 gene can be directly regulated by E2F1 transcription factor and that Apaf-1 is a direct transcriptional target of the tumor suppressor p53.”
BackgroundDifferential regulation of E2F1 apoptotic target genes in response to DNA damage
Pediconi, N., Ianari, A., Costanzo, A., Belloni, L., Gallo, R., Cimino, L., Porcellini, A., Screpanti, I., Balsano, C., Alesse, E., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb998 · Cited by 266
Rho kinase in the regulation of cell death and survival
Shi, J., & Wei, L. (2007) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-007-0009-7 · Cited by 254
“The reduced activity of E2F1 [30], which is a transcriptional regulator of Apaf-1 [93] in terminally differentiated cardiomyocytes, is likely to contribute to the marked reduction of Apaf-1 in these cells.”
BackgroundInfluentialAPAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.
Robles, A. I., Bemmels, N. A., Foraker, A. B., & Harris, C. C. (2001) · PubMed · Cited by 250
Hallstrom, T. C., Mori, S., & Nevins, J. R. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.11.031 · Cited by 249
Lysosomal destabilization in p53-induced apoptosis
Yuan, X.-M., Li, W., Dalen, H., Lotem, J., Kama, R., Sachs, L., & Brunk, U. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092135599 · Cited by 226
Studies on modulation of the activity of tumor suppressor protein p53
Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 247
The role of p53 and pRB in apoptosis and cancer
Hickman, E. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00265-9 · Cited by 214
Self-citationApoptotic cell death regulation in neurons
Hollville, E., Romero, S. E., & Deshmukh, M. (2019) · The FEBS Journal · doi:10.1111/febs.14970 · Cited by 214
E2F and cell cycle control: a double-edged sword
Stevens, C., & La Thangue, N. B. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00054-7 · Cited by 205
Olsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402196 · Cited by 200
Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function
Schlisio, S. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf577 · Cited by 197
Denchi, E. L., Attwooll, C., Pasini, D., & Helin, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2660-2672.2005 · Cited by 195
Self-citationAPAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death
Fortin, A., Cregan, S. P., MacLaurin, J. G., Kushwaha, N., Hickman, E. S., Thompson, C. S., Hakim, A., Albert, P. R., Cecconi, F., Helin, K., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105137 · Cited by 194
“The studies of Moroni et al. (2001) also identified potential p53 response elements within the APAF1 promoter and demonstrated APAF1 promoter activation in tumor cell lines overexpressing p53.”
BackgroundMethodSelf-citationGinsberg, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03270-2 · Cited by 187
C. elegans ced-13 can promote apoptosis and is induced in response to DNA damage
Schumacher, B., Schertel, C., Wittenburg, N., Tuck, S., Mitani, S., Gartner, A., Conradt, B., & Shaham, S. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401539 · Cited by 186
Specificity in the activation and control of transcription factor E2F-dependent apoptosis
Hallstrom, T. C., & Nevins, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1831408100 · Cited by 153
Wang, J., Xiao, X., Zhang, Y., Shi, D., Chen, W., Fu, L., Liu, L., Xie, F., Kang, T., Huang, W., et al. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.00973.x · Cited by 185
“Apaf-1 is a transcriptional target of p53 and a key factor in the mitochondrial apoptotic pathway [38].”
BackgroundDick, F. A., & Dyson, N. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00344-7 · Cited by 179
Direct repression of the Mcl-1 promoter by E2F1
Croxton, R., Ma, Y., Song, L., Haura, E. B., & Cress, W. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205157 · Cited by 183
“…apoptosis require the functional transcriptional activity of E2F1 to induce the expression of p19ARF, p73, or Apaf-1 (Bates et al., 1998; Irwin et al., 2000; Kowalik et al., 1998; Moroni et al., 2001; Stiewe and Putzer, Figure 2 Constitutive Mcl-1 expression blocks E2F1-induced apoptosis.”
BackgroundLiu, K., Luo, Y., Lin, F.-T., & Lin, W.-C. (2004) · Genes & Development · doi:10.1101/gad.1180204 · Cited by 147
“Specifically, the role of E2F1 protein as a signal for apoptosis and the inducer of p73 (Irwin et al. 2000; Lissy et al. 2000; Pediconi et al. 2003), p53 (Kowalik et al. 1998), caspase (Nahle et al. 2002), and Apaf1 (Moroni et al. 2001; Furukawa et al. 2002) has defined a pathway that links Rb/E2F cell cycle control w…”
Backgroundp73 Is Required for Survival and Maintenance of CNS Neurons
Pozniak, C. D., Barnabé-Heider, F., Rymar, V. V., Lee, A. F., Sadikot, A. F., & Miller, F. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09800.2002 · Cited by 146
“, 1999), Apaf1 (Fortin et al., 2001; Moroni et al., 2001), and the caspases (Cregan et al.”
BackgroundApoptosis in Cancer Biology and Therapy
Moyer, A., Tanaka, K., & Cheng, E. H. (2025) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-115023 · Cited by 173
Suppression of the Intrinsic Apoptosis Pathway by Synaptic Activity
Léveillé, F., Papadia, S., Fricker, M., Bell, K. F. S., Soriano, F. X., Martel, M.-A., Puddifoot, C., Habel, M., Wyllie, D. J., Ikonomidou, C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5115-09.2010 · Cited by 146
“Activity of luciferase-based reporters of both the Casp9 and Apaf1 promoters (Moroni et al., 2001; Tsujimoto et al., 2005) were also suppressed by AP bursting (Fig.”
BackgroundMethodInfluentialApaf-1 Is a Mediator of E2F-1-induced Apoptosis
Furukawa, Y., Nishimura, N., Furukawa, Y., Satoh, M., Endo, H., Iwase, S., Yamada, H., Matsuda, M., Kano, Y., & Nakamura, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200805200 · Cited by 138
Sturm, I., Bosanquet, A. G., Hermann, S., Güner, D., Dörken, B., & Daniel, P. T. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401194 · Cited by 168
“In addition, such events have been linked to drug resistance in B-CLL.8,9 Approximately, 10% of B-CLL patients carry p53 mutations as a the exons 5–8, that is, the DNA-binding domain, while p53 inactivation in acute lymphatic leukemias is a rather rare event.10 Loss of p53 function may result in the deficient activati…”
BackgroundResultDynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways
Porter, G. W., Khuri, F. R., & Fu, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.003 · Cited by 167
The ARTS of p53-dependent mitochondrial apoptosis
Hao, Q., Chen, J., Lu, H., & Zhou, X. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac074 · Cited by 166
“Finally, p53 transcriptionally activates the APAF1-encoding gene, whose protein product can serve as a scaffold for apoptosome assembly and caspase activation ( Soengas et al., 1999 ; Fortin et al., 2001 ; Kannan et al., 2001 ; Moroni et al., 2001 ; Robles et al., 2001 ) .”
BackgroundMechanism of Apoptosis Induced by Curcumin in Colorectal Cancer
Ismail, N. I., Othman, I., Abas, F., H. Lajis, N., & Naidu, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102454 · Cited by 166
“It has been reported that p53 may also increase expression of apoptosis effector components such as PTEN, Apaf-1, PERP [300,301], caspase 6 [302,303], and ferredoxin reductase (FDXR) that promotes the increase in reactive oxygen species (ROS) [304].”
BackgroundThe retinoblastoma tumor-suppressor gene, the exception that proves the rule
Goodrich, D. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209616 · Cited by 164
“Gene expression profiling has suggested that E2F1 regulates genes important for apoptosis (Muller et al., 2001), including the apoptosis protease activating factor-1 gene (Apaf1) and procaspases (Moroni et al., 2001; Nahle et al., 2002).”
BackgroundInvolvement of E2F transcription factor family in cancer
Tsantoulis, P. K., & Gorgoulis, V. G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.005 · Cited by 163
“Themost importantmediators are Apaf-1 [94,95], the p53 homologue p73 [96–98], caspase-8 and caspase-9 [99] and the pro-apoptotic members of the Bcl-2 family [100].”
BackgroundLife and death decisions by E2F-1
Bell, L. A., & Ryan, K. M. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401324 · Cited by 163
“Perhaps more simple to understand are a number of reports that have recently implicated E2F-1 as being a regulator of factors intrinsic to the apoptotic process, for example, apoptosis protein-activating factor (Apaf-1).(71,72) When induced, Apaf-1 assembles with cytochrome c, a mitochondrial signal released on receip…”
BackgroundApoptotic threshold is lowered by p53 transactivation of caspase-6
MacLachlan, T. K., & El-Deiry, W. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132241599 · Cited by 162
The role of DNA damage responses in p53 biology
Speidel, D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1459-z · Cited by 160
“…pathway of apoptosis), CD95/Fas (Muller et al. 1998; OwenSchaub et al. 1995) and DR5 (Wu et al. 1997 (part of the extrinsic receptor-mediated pathway of apoptosis) and other factors, including Apaf1, Perp and Pidd (Attardi et al. 2000; Lin et al. 2000; Moroni et al. 2001; Robles et al. 2001).”
BackgroundTranscription, apoptosis and p53: catch-22
SCHULER, M., & GREEN, D. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.01.001 · Cited by 160
Alterations in G1 to S Phase Cell-Cycle Regulators during Amyotrophic Lateral Sclerosis
Ranganathan, S., & Bowser, R. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63879-5 · Cited by 160
The emerging role of E2F-1 in the DNA damage response and checkpoint control
Stevens, C., & Thangue, N. B. L. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.034 · Cited by 161
Neural cell cycle dysregulation and central nervous system diseases
Wang, W., Bu, B., Xie, M., Zhang, M., Yu, Z., & Tao, D. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.007 · Cited by 159
E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7
Logan, N. A., Graham, A., Zhao, X., Fisher, R., Maiti, B., Leone, G. W., & Thangue, N. B. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208703 · Cited by 156
Regulation of E2F1 by BRCT Domain-Containing Protein TopBP1
Liu, K., Lin, F.-T., Ruppert, J. M., & Lin, W.-C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3287-3304.2003 · Cited by 132
“In comparison, overexpression of E2F2 or E2F3 was shown to induce apoptosis as well, but to a lesser extent than with E2F1 (21, 28).”
BackgroundMethodResultInfluentialThe p53 network in lung carcinogenesis
Robles, A. I., Linke, S. P., & Harris, C. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205563 · Cited by 154
“Alternatively, p53 can initiate apoptosis through the transactivation of genes such as Bax (Miyashita and Reed, 1995), Killer/DR5 (Wu et al., 1997), PIG3 (Polyak et al., 1997), and APAF-1 (Moroni et al., 2001; Robles et al., 2001).”
BackgroundmiR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma
Cai, C., ZHAO, G.-Y., Tian, L., LIU, L., YAN, K., Ma, Y., Ji, Z., Li, X., Han, K., Gao, J., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1995 · Cited by 152
“First, E2F1 induces the stabilization and activation of P53.”
InfluentialFunctional Identification of Api5 as a Suppressor of E2F-Dependent Apoptosis In Vivo
Morris, E. J., Michaud, W. A., Ji, J., Moon, N.-S., Rocco, J. W., & Dyson, N. J. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020196 · Cited by 152
“dependent apoptosome function and requires downstream effector caspase activity as reported in mammalian settings in vivo [20,45,46].”
BackgroundPirnia, F., Schneider, E., Betticher, D. C., & Borner, M. M. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401062 · Cited by 151
“, unpublished results),(48,49) our findings could be interpreted in the context of recent data, which show p53 to be crucially involved in the transcriptional activation of APAF-1.(50) Thus, the potent p53 stimulatory effect of MMC resulting in transcriptional activation of death pathway components may override the la…”
ResultE2F1 transcription factor and its impact on growth factor and cytokine signaling
Ertosun, M. G., Hapil, F. Z., & Özeş, O. N. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.001 · Cited by 146
Identification of Target Genes of the p16INK4A-pRB-E2F Pathway
Vernell, R., Helin, K., & Müller, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304930200 · Cited by 123
Self-citationPrograms for Cell Death: Apoptosis is Only One Way to Go
Blank, M., & Shiloh, Y. (2007) · Cell Cycle · doi:10.4161/cc.6.6.3990 · Cited by 145
Cytokine control of developmental programs in normal hematopoiesis and leukemia
Lotem, J., & Sachs, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205319 · Cited by 143
“…and Sachs, 1999) and Pidd (Lin et al., 2000), the mitochondrial genes p53AIP1 (Oda et al., 2000b) and PUMA (Nakano and Vousden, 2001; Yu et al., 2001), the ced-4 homolog Apaf-1 (Kannan et al., 2001; Moroni et al., 2001) and the genes PERP (Attardi et al., 2000) and p53DINP1 (Okamura et al., 2001).”
BackgroundThe emerging roles of microRNAs in the molecular responses of metabolic rate depression
Biggar, K. K., & Storey, K. B. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq045 · Cited by 142
“Many apoptosis-related genes that are transcriptionally regulated by p53 have been identified and include the pro-apoptotic factors, APAF-1, PUMA, Noxa, Bax (Moroni et al., 2001; Robles et al., 2001; Sax and El-Deiry, 2003; Shibue et al., 2003; Yu and Zhang, 2005).”
BackgroundClassic and novel roles of p53: prospects for anticancer therapy
Fuster, J. J., Sanz-Gonzalez, S. M., Moll, U. M., & Andrés, V. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.03.002 · Cited by 141
Metadata
- Authors
- Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K.
- Affiliations
- European Institute of Oncology (IT)
- University of Rome Tor Vergata (IT)
- Nerviano Medical Sciences (IT)
- Corresponding author
- Helin, Kristian
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2001-05-10
- Volume
- 3
- Issue
- 6
- Pages
- 552-558
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1497251274
- Cited by
- 593
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 15 · 2014: 9 · 2013: 22 · 2012: 22
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Apaf-1, E2F1, p53, retinoblastoma protein, transcriptional regulation, apoptosis, chemosensitivity, cancer cells, S phase entry
- MeSH terms
- Animals, DNA-Binding Proteins, Embryo, Mammalian, Humans, Promoter Regions, Genetic, Proteins, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cell Cycle Proteins, E2F Transcription Factors, E2F1 Transcription Factor, Mice, Apoptotic Protease-Activating Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.